Peripheral Arterial Disease Global Market Report 2024

Description

“Peripheral Arterial Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral arterial disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral arterial disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The peripheral arterial disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users
Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson Limited; Abbott Laboratories; Medtronic Plc; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Peripheral Arterial Disease (PAD) is a medical condition characterized by the narrowing or obstruction of arteries, primarily those supplying blood to the legs and feet. This condition is a type of atherosclerosis, where fat deposits (plaque) accumulate in the arteries, leading to diminished blood flow. The treatment of PAD typically involves a multifaceted approach, incorporating lifestyle adjustments, medication regimens, and medical procedures. The objective is to augment blood supply to the affected extremities, alleviate symptoms, and mitigate associated risks.

The primary treatment modalities for Peripheral Arterial Disease encompass devices, catheters, drugs, and other interventions. Devices for PAD pertain to specialized medical tools employed in the diagnosis, treatment, and management of the condition. These treatments can be administered through various routes, including oral, parenteral, and others. They find application across a spectrum of end-users, such as hospitals, specialty clinics, and other healthcare facilities.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4 billion in 2023 to $4.36 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring.

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $6.05 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns.

The increasing incidence of cardiac diseases is expected to be a significant driver for the growth of the peripheral arterial disease market in the coming years. Cardiac disease, a common heart condition, affects the main blood vessels supplying blood to the heart muscle. Peripheral arterial disease treatment plays a crucial role in aiding cardiac patients by improving blood flow, reducing cardiovascular risks, alleviating symptoms, and ultimately enhancing their overall quality of life. For instance, in June 2023, the Center for Disease Control and Prevention, a US-based government agency, reported that the number of deaths attributed to cardiovascular diseases had reached 695,547 in 2021. Additionally, as of April 2022, the American College of Cardiology, a US-based non-profit medical association, predicted a 30.7% increase in the risk factors for ischemic heart disease, with an estimated 29 million cases by 2025. Therefore, the growing prevalence of cardiac diseases acts as a significant driving force for the peripheral arterial disease market.

The increasing prevalence of diabetes is poised to be a significant driver for the growth of the peripheral arterial disease market in the foreseeable future. Diabetes, a chronic metabolic condition characterized by elevated blood glucose levels, is on the rise globally. With the growing prevalence of diabetes, there is a parallel surge in the demand for treatments addressing this condition. This surge is particularly notable in relation to peripheral arterial disease (PAD). Individuals with diabetes face an elevated risk of developing atherosclerosis, which is the primary cause of PAD and necessitates treatment. For instance, as of July 2021, the International Diabetes Federation (IDF), a Belgium-based diabetes organization, projected that the global population with diabetes would reach 537 million in 2021, 643 million in 2030, and 783 million in 2045. Additionally, it was estimated that 541 million people would experience impaired glucose tolerance by 2021. Furthermore, it was anticipated that nearly 6.7 million individuals between the ages of 20 and 79 would succumb to complications related to diabetes in 2021. Therefore, the escalating prevalence of diabetes stands as a significant driving force for the growth of the peripheral arterial disease market.

The insufficiency of healthcare infrastructure is anticipated to impede the growth of the peripheral arterial disease market. A dearth of accessible healthcare services can pose significant challenges for patients in obtaining the necessary drugs and treatments, especially in developing economies where resources and infrastructure may be limited. For instance, as of June 2023, the National Rural Health Alliance, a non-profit organization based in Australia, reported that over 7 million individuals, which constitutes over a third of Australia's population, bear a disproportionate burden of illness and premature mortality, partly due to inadequate healthcare spending. This indicates a significant gap in healthcare infrastructure. Therefore, the deficiency in healthcare infrastructure stands as a substantial constraint on the growth of the peripheral arterial disease market.

Prominent companies in the peripheral arterial disease market are dedicated to the development of cutting-edge drugs and solutions to maintain their competitive edge. This emphasis on drug innovation holds the potential to yield more effective treatments for PAD, ultimately reducing the risk of complications and enhancing patient outcomes. For instance, in August 2021, The Janssen Pharmaceutical Companies, a Belgium-based pharmaceutical firm, obtained an expanded indication for peripheral artery disease (PAD) for the XARELTO (rivaroxaban) dose from the Food and Drug Administration (FDA), a US-based government agency. Notably, XARELTO stands as the first and only therapy approved for both coronary artery disease (CAD) and PAD, including PAD patients post-LER (lower extremity revascularization). This medication is also recommended for patients dealing with acute limb ischemia and amputation, ischemic stroke, and myocardial infarction.

In February 2023, Abbott Laboratories, a prominent US-based pharmaceutical company, successfully completed its acquisition of Cardiovascular Systems Inc. for a total of $890 million. Through this strategic acquisition, Abbott intends to fortify its cardiovascular portfolio by integrating new and complementary technologies. Cardiovascular Systems Inc., based in the US, is a leading medical device company specializing in the development and commercialization of products tailored for the treatment of peripheral and coronary vascular disease.

Major players in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC .

North America was the largest region in the peripheral artery disease market in 2023. The regions covered in peripheral artery disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of sales of cardiac medical devices and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12345

1. Executive Summary

2. Peripheral Arterial Disease Market Characteristics

3. Peripheral Arterial Disease Market Trends And Strategies

4. Peripheral Arterial Disease Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Peripheral Arterial Disease Market Size and Growth

5.1. Global Peripheral Arterial Disease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Peripheral Arterial Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Peripheral Arterial Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Peripheral Arterial Disease Market Segmentation

6.1. Global Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Devices
Catheters
Drugs
Other Types
6.2. Global Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Route of Administrations
6.3. Global Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Others End-Users

7. Peripheral Arterial Disease Market Regional And Country Analysis

7.1. Global Peripheral Arterial Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Peripheral Arterial Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Peripheral Arterial Disease Market

8.1. Asia-Pacific Peripheral Arterial Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Peripheral Arterial Disease Market

9.1. China Peripheral Arterial Disease Market Overview
9.2. China Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Peripheral Arterial Disease Market

10.1. India Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Peripheral Arterial Disease Market

11.1. Japan Peripheral Arterial Disease Market Overview
11.2. Japan Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Peripheral Arterial Disease Market

12.1. Australia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Peripheral Arterial Disease Market

13.1. Indonesia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Peripheral Arterial Disease Market

14.1. South Korea Peripheral Arterial Disease Market Overview
14.2. South Korea Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Peripheral Arterial Disease Market

15.1. Western Europe Peripheral Arterial Disease Market Overview
15.2. Western Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Peripheral Arterial Disease Market

16.1. UK Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Peripheral Arterial Disease Market

17.1. Germany Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Peripheral Arterial Disease Market

18.1. France Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Peripheral Arterial Disease Market

19.1. Italy Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Peripheral Arterial Disease Market

20.1. Spain Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Peripheral Arterial Disease Market

21.1. Eastern Europe Peripheral Arterial Disease Market Overview
21.2. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Peripheral Arterial Disease Market

22.1. Russia Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Peripheral Arterial Disease Market

23.1. North America Peripheral Arterial Disease Market Overview
23.2. North America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Peripheral Arterial Disease Market

24.1. USA Peripheral Arterial Disease Market Overview
24.2. USA Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Peripheral Arterial Disease Market

25.1. Canada Peripheral Arterial Disease Market Overview
25.2. Canada Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Peripheral Arterial Disease Market

26.1. South America Peripheral Arterial Disease Market Overview
26.2. South America Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Peripheral Arterial Disease Market

27.1. Brazil Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Peripheral Arterial Disease Market

28.1. Middle East Peripheral Arterial Disease Market Overview
28.2. Middle East Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Peripheral Arterial Disease Market

29.1. Africa Peripheral Arterial Disease Market Overview
29.2. Africa Peripheral Arterial Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Peripheral Arterial Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Peripheral Arterial Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Peripheral Arterial Disease Market Competitive Landscape And Company Profiles

30.1. Peripheral Arterial Disease Market Competitive Landscape
30.2. Peripheral Arterial Disease Market Company Profiles
- 30.2.1. Cardinal Health Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson and Johnson Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Medtronic Plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Becton Dickinson and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Peripheral Arterial Disease Market Other Major And Innovative Companies

31.1. Koninklijke Philips N.V.
31.2. Boston Scientific Corporation
31.3. B. Braun SE
31.4. Terumo Corp.
31.5. Cook Medical LLC
31.6. Penumbra Inc.
31.7. Shockwave Medical Inc.
31.8. AngioDynamics Inc.
31.9. Cardiovascular Systems Inc.
31.10. ACIST Medical Systems Inc.
31.11. SurModics Inc.
31.12. Endologix Inc.
31.13. BioVentrix Inc.
31.14. QT Vascular Ltd.
31.15. Avinger Inc.

32. Global Peripheral Arterial Disease Market Competitive Benchmarking

33. Global Peripheral Arterial Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peripheral Arterial Disease Market

35. Peripheral Arterial Disease Market Future Outlook and Potential Analysis

35.1 Peripheral Arterial Disease Market In 2028 - Countries Offering Most New Opportunities
35.2 Peripheral Arterial Disease Market In 2028 - Segments Offering Most New Opportunities
35.3 Peripheral Arterial Disease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer